OverviewChartNewsTraderScreen

BNP Paribas Knock-Out PGR/  DE000PC47J21  /

EUWAX
2024-04-30  6:47:05 PM Chg.-0.11 Bid6:55:50 PM Ask6:55:50 PM Underlying Strike price Expiration date Option type
3.26EUR -3.26% 3.24
Bid Size: 3,861		 3.25
Ask Size: 3,861		 Progressive Corporat... 173.2146 USD 2078-12-31 Call
GlobeNewswire 5:58 PM Great Plains Communications Offers Support to Communities and Customers Impacted by Tornado and Stor...
GlobeNewswire 4:00 PM RS BioTherapeutics Launches Crowdfunding Campaign Through StartEngine
GlobeNewswire 2:00 PM Route 92 Medical Announces FDA 510(k) Clearance for FreeClimb 54 Reperfusion System
GlobeNewswire 1:05 PM Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth St...
GlobeNewswire 12:05 PM MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic Diseases
GlobeNewswire 11:00 AM CDR-Life Announces Fourth Milestone Achievement with Boehringer Ingelheim in Phase 1 Geographic Atro...
GlobeNewswire 04-25 Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Re...
GlobeNewswire 04-25 Opthea to Present at the OIS Retina Innovation Summit at ARVO
TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 04-24 Freeline to Present New Data on its Gaucher and Parkinson’s Disease Programs at the American Society...
TeleTrader 04-23 Biden meets AOC amid divide on Israel policy
GlobeNewswire 04-22 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...
GlobeNewswire 04-22 Tiziana Life Sciences Announces Additional Clinical Improvements Among Multiple Sclerosis Patients i...
GlobeNewswire 04-19 Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Scleros...
GlobeNewswire 04-18 Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with B...
GlobeNewswire 04-18 TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...
GlobeNewswire 04-18 Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting...
GlobeNewswire 04-18 TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the P...
GlobeNewswire 04-17 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IP, NXPL, NS, RXMD
GlobeNewswire 04-17 Kuehn Law Encourages NS, NXPL, IP, and RXMD Investors to Contact Law Firm
GlobeNewswire 04-17 Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American ...
GlobeNewswire 04-16 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire 04-15 Zevra Therapeutics Presents New Data on the Long-Term Safety and Efficacy of Arimoclomol as a Treatm...
GlobeNewswire 04-15 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Ho...
GlobeNewswire 04-15 TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis...